FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000992267> ?p ?o ?g. }

• W2000992267 abstract "This case study describes how a public-private partnership between Medicinesfor Malaria Venture (MMV) and Sigma-Tau Industrie Farmaceutiche Riunite SpAachieved international regulatory approval for use of the fixed-doseartemisinin-based combination therapy dihydroartemisinin-piperaquine(Eurartesim®) for the treatment of malaria, enablingmore widespread access to the medicine in malaria-endemic countries. The combination of dihydroartemisinin and piperaquine demonstrated success inclinical trials for the treatment of malaria in Asia and Africa in the2000s. However, as it had not been developed to international regulatorystandards it was out of the reach of the majority of patients indisease-endemic countries, particularly those reliant on public healthcaresystems supported by international donor funding. To overcome this, as of2004 MMV worked in partnership with Sigma-Tau, Holleykin, Oxford University,the Institute of Tropical Medicine Antwerp, and the National Institute ofMalaria Research India to develop the dihydroartemisinin-piperaquinecombination to international standards. In 2011, the European Commissiongranted full marketing authorization to Sigma-Tau for Eurartesim. The partnership between MMV, Sigma-Tau, and numerous other academic andindustrial partners across the world, led to the successful development toEMA regulatory standards of a high-quality and highly efficaciousanti-malarial treatment that otherwise would not have been possible. Thedossier has also been submitted to the WHO for prequalification, and asafety statement to guide correct use of Eurartesim has been produced. InJuly 2012, the first delivery to a disease-endemic country was made toCambodia, where the medicine is being used to treat patients and helpcounter the emergence of artemisinin resistance in the area. A paediatricdispersible formulation of Eurartesim is being developed, with the objectiveto submit the dossier to the EMA by the end of 2014. The development of Eurartesim to international regulatory standardsexemplifies the strengths of the product development partnership model inutilising the individual skills and expertise of partners with differingobjectives to achieve a common goal. Successful uptake of Eurartesim bypublic health systems in malaria-endemic countries poses new challenges,which may require additional partnerships as we move forward." @default.
• W2000992267 created "2016-06-24" @default.
• W2000992267 creator A5013588389 @default.
• W2000992267 creator A5032048186 @default.
• W2000992267 date "2013-06-19" @default.
• W2000992267 modified "2023-10-15" @default.
• W2000992267 title "MMV in partnership: the Eurartesim® experience" @default.
• W2000992267 cites W1569685087 @default.
• W2000992267 cites W1800697583 @default.
• W2000992267 cites W1970461627 @default.
• W2000992267 cites W1981589246 @default.
• W2000992267 cites W2010067521 @default.
• W2000992267 cites W2013035959 @default.
• W2000992267 cites W2030481162 @default.
• W2000992267 cites W2052262611 @default.
• W2000992267 cites W2072894930 @default.
• W2000992267 cites W2082480743 @default.
• W2000992267 cites W2097116672 @default.
• W2000992267 cites W2098923921 @default.
• W2000992267 cites W2128743785 @default.
• W2000992267 cites W2138525153 @default.
• W2000992267 cites W2139891194 @default.
• W2000992267 cites W2140533141 @default.
• W2000992267 cites W2147189420 @default.
• W2000992267 cites W2150330391 @default.
• W2000992267 cites W2157656397 @default.
• W2000992267 cites W2161141025 @default.
• W2000992267 cites W2161917102 @default.
• W2000992267 cites W2168375705 @default.
• W2000992267 cites W2169177655 @default.
• W2000992267 cites W2169843453 @default.
• W2000992267 cites W2322093531 @default.
• W2000992267 doi "https://doi.org/10.1186/1475-2875-12-211" @default.
• W2000992267 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3691732" @default.
• W2000992267 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23782869" @default.
• W2000992267 hasPublicationYear "2013" @default.
• W2000992267 type Work @default.
• W2000992267 sameAs 2000992267 @default.
• W2000992267 citedByCount "18" @default.
• W2000992267 countsByYear W20009922672014 @default.
• W2000992267 countsByYear W20009922672015 @default.
• W2000992267 countsByYear W20009922672016 @default.
• W2000992267 countsByYear W20009922672017 @default.
• W2000992267 countsByYear W20009922672018 @default.
• W2000992267 countsByYear W20009922672021 @default.
• W2000992267 countsByYear W20009922672022 @default.
• W2000992267 countsByYear W20009922672023 @default.
• W2000992267 crossrefType "journal-article" @default.
• W2000992267 hasAuthorship W2000992267A5013588389 @default.
• W2000992267 hasAuthorship W2000992267A5032048186 @default.
• W2000992267 hasBestOaLocation W20009922671 @default.
• W2000992267 hasConcept C138816342 @default.
• W2000992267 hasConcept C142724271 @default.
• W2000992267 hasConcept C159110408 @default.
• W2000992267 hasConcept C162324750 @default.
• W2000992267 hasConcept C17744445 @default.
• W2000992267 hasConcept C185032368 @default.
• W2000992267 hasConcept C199539241 @default.
• W2000992267 hasConcept C203014093 @default.
• W2000992267 hasConcept C2776120307 @default.
• W2000992267 hasConcept C2776553905 @default.
• W2000992267 hasConcept C2777589142 @default.
• W2000992267 hasConcept C2778048844 @default.
• W2000992267 hasConcept C2778371730 @default.
• W2000992267 hasConcept C50522688 @default.
• W2000992267 hasConcept C60644358 @default.
• W2000992267 hasConcept C71750763 @default.
• W2000992267 hasConcept C71924100 @default.
• W2000992267 hasConcept C86803240 @default.
• W2000992267 hasConceptScore W2000992267C138816342 @default.
• W2000992267 hasConceptScore W2000992267C142724271 @default.
• W2000992267 hasConceptScore W2000992267C159110408 @default.
• W2000992267 hasConceptScore W2000992267C162324750 @default.
• W2000992267 hasConceptScore W2000992267C17744445 @default.
• W2000992267 hasConceptScore W2000992267C185032368 @default.
• W2000992267 hasConceptScore W2000992267C199539241 @default.
• W2000992267 hasConceptScore W2000992267C203014093 @default.
• W2000992267 hasConceptScore W2000992267C2776120307 @default.
• W2000992267 hasConceptScore W2000992267C2776553905 @default.
• W2000992267 hasConceptScore W2000992267C2777589142 @default.
• W2000992267 hasConceptScore W2000992267C2778048844 @default.
• W2000992267 hasConceptScore W2000992267C2778371730 @default.
• W2000992267 hasConceptScore W2000992267C50522688 @default.
• W2000992267 hasConceptScore W2000992267C60644358 @default.
• W2000992267 hasConceptScore W2000992267C71750763 @default.
• W2000992267 hasConceptScore W2000992267C71924100 @default.
• W2000992267 hasConceptScore W2000992267C86803240 @default.
• W2000992267 hasIssue "1" @default.
• W2000992267 hasLocation W20009922671 @default.
• W2000992267 hasLocation W20009922672 @default.
• W2000992267 hasLocation W20009922673 @default.
• W2000992267 hasLocation W20009922674 @default.
• W2000992267 hasOpenAccess W2000992267 @default.
• W2000992267 hasPrimaryLocation W20009922671 @default.
• W2000992267 hasRelatedWork W1879183551 @default.
• W2000992267 hasRelatedWork W2096919908 @default.
• W2000992267 hasRelatedWork W2135690415 @default.
• W2000992267 hasRelatedWork W2912542934 @default.
• W2000992267 hasRelatedWork W2944148154 @default.
• W2000992267 hasRelatedWork W2950531058 @default.

• next